Relative efficacy of bivalirudin versus heparin monotherapy in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: a network meta-analysis

Relative efficacy of bivalirudin versus heparin monotherapy in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: a network meta-analysis

Tim Kinnaird,1 Goran Medic,2 Gianni Casella,3 Francois Schiele,4 Upendra Kaul,5 Peter W Radke,6 Indra Eijgelshoven,2 Gert Bergman,2 Derek P Chew71Cardiff and Vale University Health Board, Cardiff, UK; 2Mapi-Health Economics Outcomes Research and Strategic Market Access, Houten, the Netherlands; 3Osp...

Full description

Bibliographic Details
Main Authors:	Kinnaird T, Medic G, Casella G, Schiele F, Kaul U, Radke PW, Eijgelshoven I, Bergman G, Chew DP
Format:	Article
Language:	English
Published:	Dove Medical Press 2013-10-01
Series:	Journal of Blood Medicine
Online Access:	http://www.dovepress.com/relative-efficacy-of-bivalirudin-versus-heparin-monotherapy-in-patient-a14550

Similar Items

Comparison of anti-thrombotic strategies using Bivalirudin, Heparin plus Glycoprotein IIb/IIIa inhibitors and Unfractionated Heparin Monotherapy for patients undergoing percutaneous coronary intervention – A single centre observational study
by: Upendra Kaul, et al.
Published: (2015-07-01)

Bivalirudin in percutaneous coronary intervention
by: Sam J Lehman, et al.
Published: (2006-12-01)

Bivalirudin vs. heparin on a background of ticagrelor and aspirin in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: A multicenter prospective cohort study
by: Xiao-Fan Yu, et al.
Published: (2022-10-01)

Efficacy and safety of heparin, heparin+GPI, bivalirudin during PCI – A prospective real world study
by: A. Dua, et al.
Published: (2014-11-01)

Bivalirudin for cardiopulmonary bypass in a patient with heparin allergy
by: Emre Boysan, et al.
Published: (2023-09-01)

Efficacy and safety of bivalirudin application during primary percutaneous coronary intervention in older patients with acute ST-segment elevation myocardial infarction
by: Hongwu Chen, et al.
Published: (2020-09-01)

One-Year Safety and Effectiveness of Bivalirudin versus Heparin in Patients Undergoing Elective Percutaneous Coronary Intervention
by: Jiawen Li, et al.
Published: (2023-07-01)

Antithrombotic efficacy of bivalirudin compared to unfractionated heparin during percutaneous coronary intervention for acute coronary syndrome
by: Corinne Frere, et al.
Published: (2019-01-01)

Critical Appraisal of Bivalirudin versus Heparin for Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Trials.
by: Anthony A Bavry, et al.
Published: (2015-01-01)

Bivalirudin in combination with heparin to control mesenchymal cell procoagulant activity.
by: Xavier Stephenne, et al.
Published: (2012-01-01)

Extracorporeal Membrane Oxygenation Complications in Heparin- and Bivalirudin-Treated Patients
by: Katherine Giuliano, MD, et al.
Published: (2021-07-01)

Bivalirudin plus loading dose of cilostazol-based triple-antiplatelet in treatment of non-ST-elevation myocardial infarction following percutaneous coronary intervention
by: Wang M, et al.
Published: (2015-09-01)

Safety of Bivalirudin Combined with Ticagrelor in the Emergency PCI in Patients with Acute ST-Segment Elevation Myocardial Infarction
by: Zheng-Dong Wang, et al.
Published: (2022-12-01)

Distinct effects of unfractionated heparin versus bivalirudin on circulating angiogenic peptides.
by: Navin K Kapur, et al.
Published: (2012-01-01)

Effect of heparin and Bivalirudin on the kinetics of clot formation: Viscoelastic coagulation testing
by: Suruchi Hasija, et al.
Published: (2017-01-01)

A meta‐analysis and cost‐minimization analysis of bivalirudin versus heparin in high‐risk patients for percutaneous coronary intervention
by: Ke‐Xin Sun, et al.
Published: (2021-05-01)

Reperfusion After Fibrinolytic Therapy (RAFT): An open-label, multi-centre, randomised controlled trial of bivalirudin versus heparin in rescue percutaneous coronary intervention.
by: Amir Faour, et al.
Published: (2021-01-01)

Reperfusion After Fibrinolytic Therapy (RAFT): An open-label, multi-centre, randomised controlled trial of bivalirudin versus heparin in rescue percutaneous coronary intervention
by: Amir Faour, et al.
Published: (2021-01-01)

Comprehensive safety profile evaluation of bivalirudin in Chinese ST-segment elevation myocardial infarction patients receiving percutaneous coronary intervention: a prospective, multicenter, intensive monitoring study
by: Haijun Zheng, et al.
Published: (2022-06-01)

Outcome of the HORIZONS-AMI trial: bivalirudin enhances long-term survival in patients with ST-elevation myocardial infarction undergoing angioplasty
by: Feldman DN, et al.
Published: (2012-02-01)

Bivalirudin for cardiac catheterization in a pediatric patient with religious objection to the use of porcine-derived heparin
by: A. Caskey, et al.
Published: (2021-08-01)

Bivalirudin versus Heparin plus Glycoprotein IIb/IIIa Inhibitors in Women Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials.
by: Haiyan Xu, et al.
Published: (2017-01-01)

Percutaneous coronary intervention in patients with acute coronary syndrome: focus on bivalirudin
by: Ravi K Ramana, et al.
Published: (2008-06-01)

Heparin-based versus bivalirudin-based anticoagulation in pediatric extracorporeal membrane oxygenation: A systematic review
by: Carlos A. Valdes, et al.
Published: (2023-03-01)

Superiority of bivalirudin over heparin anticoagulation therapy for extracorporeal membrane oxygenation? Too early to draw conclusions
by: Jie Gu, et al.
Published: (2023-02-01)

Bivalirudin vs heparin in cardiac-cerebral ischemic and bleeding events among Chinese STEMI patients during percutaneous coronary intervention: a retrospective cohort study
by: Zhichao Bai, et al.
Published: (2023-11-01)

Successful intraprocedural anticoagulation with bivalirudin during pulmonary vein isolation in a patient with known heparin-induced thrombocytopenia type II
by: Barbara Bellmann, MD, et al.
Published: (2016-04-01)

BIVALIRUDIN AND PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH ACUTE CORONARY SYNDROME: THEORY AND PRACTICE
by: O. V. Averkov
Published: (2012-06-01)

Results bivalirudin use in actual practice in patients with acute coronary syndrome during percutaneous coronary intervention
by: Z H Shugushev, et al.
Published: (2014-12-01)

Bivalirudin versus heparin in adult and pediatric patients with extracorporeal membrane oxygenation therapy: A systematic review and meta-analysis
by: Liyao Liu, et al.
Published: (2022-03-01)

Effects of Heparin and Bivalirudin on Thrombin-Induced Platelet Activation: Differential Modulation of PAR Signaling Drives Divergent Prothrombotic Responses
by: Mikael Lund, et al.
Published: (2021-09-01)

The Efficacy and Safety of Bivalirudin Versus Heparin in the Anticoagulation Therapy of Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis
by: Min Ma, et al.
Published: (2022-04-01)

Experience with primary percutaneous coronary interventions in ST elevation myocardial infarction in tertiary care hospital
by: Wasim Rashid, et al.
Published: (2015-12-01)

Management of Bivalirudin Anticoagulation Therapy for Extracorporeal Membrane Oxygenation in Heparin-Induced Thrombocytopenia: A Case Report and a Systematic Review
by: Han Zhong, et al.
Published: (2020-09-01)

Is it time to switch to bivalirudin for ECMO anticoagulation?
by: Amir Navaei, et al.
Published: (2023-08-01)

EXPERT CONSENSUS. THE CURRENT POSITION ON BIVALIRUDIN
by: статья Редакционная
Published: (2015-02-01)

Spontaneous atraumatic heparin-induced hemarthrosis in a patient treated for non-ST-elevation myocardial infarction
by: Inderbir Padda, MD, et al.
Published: (2023-04-01)

Percutaneous coronary intervention in the elderly with ST-segment elevation myocardial infarction
by: Gao L, et al.
Published: (2014-07-01)

Pre-emptive use of bivalirudin for emergent off-pump coronary artery bypass surgery in a suspected case of heparin-induced thrombocytopenia
by: Dharmesh R Agrawal, et al.
Published: (2012-01-01)

Safety and Effectiveness of Bivalirudin in Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis
by: Abdul Hafeez Ahmad Hamdi, et al.
Published: (2017-07-01)